Results of a gender-specific study to assess the efficacy of the Taxus paclitaxel-eluting coronary stent in women undergoing coronary revascularisation were released at the European Society of Cardiology Congress by interventional device developer Boston Scientific.
The Eastern Lithuania Cardiology Project (ELCP) - an integral inter-institutional regional project sponsored by the Lithuanian Government and the European Structural Funds, which began in 2004 - will end this year. In May, those who voted on the Lithuanian EU Support official website (a specially organised event, focusing on all EU-supported projects in all fields) nominated this project as the…
By Stefan P. Janssens, MD, PhD Russian summary and complete article in English.
Coronary stenting is the most common way of treating symptomatic ischaemic cardiopathy and stenosis of venous bypasses. Restenosis actually occurs in 30% of patients treated with non-medicated stents while "drug eluting" stents have reduced the incidence of restenosis by approximately a quarter and have proved particularly effective in diabetic patients and in the treatment of lesions…
Tissue Doppler Imaging (TDI) and contrast echocardiography open up new possibilities for exactly representing and assessing functional cardiac disturbances. This was the topic discussed by Dr. Harald Becher of John Radcliff Hospital, Oxford, and Dr. Jörg Strotmann of the University Clinic Würzburg in the framework of the Toshiba workshop “New approaches in echocardiography” at the European…
Further developments in computer and detection technology over the last few months and years have made it possible to overcome, to a large degree, the previously limitations of medical computer tomography in spatial and temporal resolution, and thus to permit “detail-true” representation of the beating heart. The diagnostic workflow and computer-tomographic diagnosis of the heart using the…
A wearable cardiac telemedicine system based on Bluetooth technology could text the local hospital if a patient is about to have a heart attack, according to a publication of two Indian researchers of the Sathyabama University in Tamil Nadu, who developed the system.
The Fred easyport, the only pocket defibrillator in the world, which Schiller brought onto the market three years ago, was a huge success so far. From next year on, the device will also supply a manual shock option. It is so small (133 x 126 x 50mm) and light (490 g including the battery) that for many doctors it is already standard equipment in their emergency bag.The fact that this ‘life…
There is no lack of IT and software solutions for putting digitisation and networks into practice; however, many hospitals wonder how the implementation will work in practice and whether the investment will prove successful.
The UK spends more of its healthcare budget on cardiovascular disease than any other country in the EU.
Previous studies have shown that tobacco smoking increases the risk ...
By Professor Gustav Steinhoff MD, director of the Department for Cardiac Surgery, and Christof Stamm MD, co-ordinator of clinical studies, at Rostock University, Germany
Professor Paul Pepe and Dr Jane Wigginton discuss current research and concepts that will affect the future of basic CPR.
Blood pressure (BP) screening, either alone or in combination with other cardiovascular risk factors such as cholesterol levels, does not determine a person's chance of having a heart attack or stroke, reports Professor Malcolm Law and colleagues at the Wolfson Institute of Preventive Medicine in the Journal of Medical Screening.
A processing system said to pick up cardiac sounds and correlate these with any related abnormalities, e.g. valve defects, stenosis, fibrillation, septal defect, etc, has been developed by the US firm Biosignetics Corporation.
For those without practised skills in using automatic external defibrillation (AED) and basic life support procedures, the prospect of coping with a case of sudden cardiac arrest is awesome.
The earlier a cardiac infarction is detected the better the patient's chances of survival. However, because tests for cardiac infarction check for protein molecules that are released from heart muscle during cell necrosis, and these enter the blood very slowly, it can take three hours to gain a reliable result.
Cardiac assist devices (CAD) are blood pumps that support the circulatory functions of severely ill cardiac patients.